Cardiology
Clinical
Anticoagulant therapy for AFib in patients with end-stage renal disease
Apixaban may be safer than warfarin for patients who have ESRD and who plan for anticoagulation because of AFib.
Clinical
Treating children with Kawasaki disease and coronary enlargement
An important new study reveals a treatment protocol that decreases the rate of aneurysm enlargement.
News
Dapagliflozin meets primary endpoint in the DAPA-HF trial
AstraZeneca announces preliminary results in first heart failure trial in an SGLT2 inhibitor.
News
New biomarker model outmatches conventional risk factors for predicting mortality
Although the majority of these biomarkers have been associated with mortality before, this is the first study that shows their independent effect...
News
Post-TAVR anticoagulation alone fails to cut stroke risk in AFib
By contrast, antiplatelet therapy linked to reduced risk of stroke, whether or not oral anticoagulation was used in this PARTNER II substudy.
News
Study: Cardiac biomarkers predicted CV events in CAP
The results suggest a change in usual practice is needed to reduce cardiovascular community-acquired pneumonia complications, according to a study...
News
Algorithm boosts MACE prediction in patients with chest pain
High-sensitivity cardiac troponin measurements combined with ECG and clinical assessment can help rule out MACE and unstable angina.
News
Sepsis survivors’ persistent immunosuppression raises mortality risk
Individuals with persistent biomarkers of inflammation and immunosuppression had a higher risk of readmission and death because of cardiovascular...
News
Older patients who stop statins may be increasing their cardiovascular risk
Discontinuation of statins was associated with an increased risk of hospital admission for a cardiovascular event.
News
AI technology meets AFib detection
An AI-enabled ECG model suggests clinical implications for early identification of atrial fibrillation.